MétaCan
Menu
Back to cohort
Record W3015287736 · doi:10.1017/cjn.2020.66

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations

2020· review· en· W3015287736 on OpenAlexafffundvenueabout
Mark S. Freedman, Virginia Devonshire, Pierre Duquette, Paul S. Giacomini, Fabrizio Giuliani, Michael C. Levin, Xavier Montalbán, Sarah A. Morrow, Jiwon Oh, Dalia Rotstein, E. Ann Yeh

Bibliographic record

VenueCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2020
Typereview
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsLondon Health Sciences CentreSt. Michael's HospitalUniversity of SaskatchewanUniversity of AlbertaCentre Hospitalier de l’Université de MontréalHospital for Sick ChildrenUniversity of British ColumbiaOttawa HospitalMontreal Neurological Institute and HospitalUniversity of Ottawa
FundersCanadian Institutes of Health ResearchSanofi GenzymeCelgeneMontreal Neurological Institute and HospitalU.S. Food and Drug AdministrationEMD SeronoSanofiMultiple Sclerosis International FederationMultiple Sclerosis Society of CanadaHospital for Sick ChildrenUniversité de MontréalUniversité LavalCentre Hospitalier Universitaire de QuébecMultiple Sclerosis SocietyUniversity of AlbertaOntario Institute for Regenerative MedicineOttawa Hospital Research InstituteMcMaster UniversityAlexion PharmaceuticalsSick Kids FoundationLondon Health Sciences CentreBiogenTeva Pharmaceutical IndustriesNational Multiple Sclerosis Society
KeywordsMultiple sclerosisMedicineDiseaseIntensive care medicineDisease controlInternal medicinePsychiatry

Abstract

fetched live from OpenAlex

The Canadian Multiple Sclerosis Working Group has updated its treatment optimization recommendations (TORs) on the optimal use of disease-modifying therapies for patients with all forms of multiple sclerosis (MS). Recommendations provide guidance on initiating effective treatment early in the course of disease, monitoring response to therapy, and modifying or switching therapies to optimize disease control. The current TORs also address the treatment of pediatric MS, progressive MS and the identification and treatment of aggressive forms of the disease. Newer therapies offer improved efficacy, but also have potential safety concerns that must be adequately balanced, notably when treatment sequencing is considered. There are added discussions regarding the management of pregnancy, the future potential of biomarkers and consideration as to when it may be prudent to stop therapy. These TORs are meant to be used and interpreted by all neurologists with a special interest in the management of MS.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.986
Threshold uncertainty score0.790

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.016
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.003
Bibliometrics0.0060.006
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0040.001
Research integrity0.0040.004
Insufficient payload (model declined to judge)0.0090.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.250
GPT teacher head0.356
Teacher spread0.107 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations126
Published2020
Admission routes4
Has abstractyes

Explore more

Same venueCanadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesSame topicMultiple Sclerosis Research StudiesFrench-language works237,207